Stonnington Group, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Stonnington Group, LLC

  • $381 Million
  • Q1 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 08, 2022
SELL
$548.35 - $738.84 $274,175 - $369,420
-500 Reduced 52.63%
450 $273,000
Q1 2022

Apr 12, 2022
BUY
$595.12 - $698.43 $357,072 - $419,057
600 Added 171.43%
950 $686,000
Q4 2021

Jan 12, 2022
BUY
$543.48 - $670.97 $190,218 - $234,839
350 New
350 $219,000

Others Institutions Holding REGN

# of Institutions
1,529
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Stonnington Group, LLC Portfolio

Follow Stonnington Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonnington Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonnington Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email